University of California San Francisco

Give to UCSF
Advanced
701 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics
Displaying 691 - 701 of 701
  • Mysterious Snake Disease Decoded

    A novel virus has been identified as the possible cause of a common but mysterious disease that kills a significant number of pet snakes all over the world, thanks to research led by scientists at the University of California, San Francisco (UCSF)—and three snakes named Juliet, Balthazar and Larry.

  • Hepatitis: UCSF and San Francisco at Ground Zero

    <p>Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. and more than 30,000 in San Francisco, alone —&nbsp;but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.</p>

    Placeholder image
  • Hepatitis C: Urgency to Fight Viral Foe Grows in the Suburbs and on the Streets

    <p>At the edge of a San Francisco neighborhood that has been riddled with drug addiction for decades, UCSF epidemiologist Kimberly Page, PhD, MPS, leads a research team that provides outreach, screening and prevention programs for drug users, those who are especially vulnerable to hepatitis C infection.</p>

  • Hepatitis B and Liver Cancer Among Asian Americans

    <p>Liver cancer is expected to become more common in the United States in coming years. “It’s deadly and it’s preventable,” says UCSF physician and researcher Tung Nguyen, MD.</p>

    Placeholder image
  • Lab Tests Show Arthritis Drug Effective Against Global Parasite

    A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.

    Placeholder image
  • Fighting Infections: Old Drug Reveals New Tricks

    A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.

  • The Coming Dearth of Doctors who Specialize in HIV/AIDS

    <p>As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.</p>

    Placeholder image